CFIGF
vs
C
8592
CFIGF
Over the past 12 months, CFIGF has significantly outperformed China Regenerative Medicine International Ltd, delivering a return of +27% compared to the China Regenerative Medicine International Ltd's 0% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
CFIGF
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Challenger Ltd
OTC:CFIGF
|
5.4
USD
|
|||||
|
C
|
China Regenerative Medicine International Ltd
HKEX:8592
|
0.98
HKD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
CFIGF, 8592
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Challenger Ltd
Revenue
|
|||||||||||
|
C
|
China Regenerative Medicine International Ltd
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
CFIGF, 8592
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Challenger Ltd
OTC:CFIGF
|
|||||||||
|
C
|
China Regenerative Medicine International Ltd
HKEX:8592
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Challenger Ltd | ||||
|
C
|
China Regenerative Medicine International Ltd | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Challenger Ltd | ||||
|
C
|
China Regenerative Medicine International Ltd | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Challenger Ltd | ||||
|
C
|
China Regenerative Medicine International Ltd | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Challenger Ltd | ||||
|
C
|
China Regenerative Medicine International Ltd | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Challenger Ltd | ||||
|
C
|
China Regenerative Medicine International Ltd | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Challenger Ltd | ||||
|
C
|
China Regenerative Medicine International Ltd | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Challenger Ltd | ||||
|
C
|
China Regenerative Medicine International Ltd | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Challenger Ltd | ||||
|
C
|
China Regenerative Medicine International Ltd | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
CFIGF, 8592
Performance By Year
CFIGF, 8592
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| ZA |
F
|
FirstRand Ltd
JSE:FSR
|
|
| US |
|
Apollo Global Management Inc
NYSE:APO
|
|
| IN |
|
Housing Development Finance Corporation Ltd
NSE:HDFC
|
|
| JP |
|
Orix Corp
TSE:8591
|
|
| IN |
|
Bajaj Finserv Ltd
NSE:BAJAJFINSV
|
|
| TW |
|
Yuanta Financial Holding Co Ltd
TWSE:2885
|
|
| KR |
|
Meritz Financial Group Inc
KRX:138040
|
|
| IT |
|
Banca Mediolanum SpA
MIL:BMED
|
|
| US |
|
Equitable Holdings Inc
NYSE:EQH
|
|
| UK |
|
M&G PLC
LSE:MNG
|